LAB.FARMACEUTICOS ROVI

27/03 CET
Closure
ISIN ES0157261019
Last:
20.7000
Dif:
-0.3000
(-1.43 %)
Volume:
20,141
1 Year Statistical Data
Data
Listed Days 255
IBEX Correlation (%) 0.76
Volatility [Y] 31.17
Alpha Ratio 0.14
Beta Ratio 0.17
Standard Deviation 1.63
Variance 2.66
Consolidated
2019-4 2019-2 Var.
Net Sales (MM€) 381.313 177.536 114.78
P.B.T (MM€) 41.880 17.464 139.83
Net Profit (MM€) 39.273 16.161 143.00
Equity (MM€) 322.389 299.310 7.71
Reserves (MM€) 0.673 0.673 0.00
Amortization (MM€) -18.216 -8.715 109.01
Net Profit/Sales (%) 10.299 9.103 13.18
Sales per share (€) N.A. N.A. N,A,
C.Increase
Thursday
01
/Nov
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 99
Percentage of the old securities:
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 33,103
Unit price to be paid in the capital increase: 15
IPO date: 01/11/2018
Capital increase starting date: 01/11/2018
capital increase ending date: 01/11/2018
Economic rights: //
Capital increase in the year: 1
Tuesday
09
/Oct
2018
Type of capital increase: Con Prima
Percentage of the new securities that are issued: 11
Percentage of the old securities: 100
Price per share: 14.5
Unit nominal of the capital increase:
Rights trading: N
Nominal amount of the capital increase: 331,034
Unit price to be paid in the capital increase: 15
IPO date: 09/10/2018
Capital increase starting date: 09/10/2018
capital increase ending date: 09/10/2018
Economic rights: //
Capital increase in the year: 1